Skip to content

Revance Therapeutics, Inc.

Delisted

CIK 1479290fmd_0X1RRQ7H8N7F9GZE3D44E3HETDManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2002 to Sep 30, 2024, 58 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading